| Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy D Singh, M Tewari, S Singh, G Narayan Future Oncology 17 (5), 581-596, 2021 | 32 | 2021 |
| VEGFa/VEGFR2 autocrine and paracrine signaling promotes cervical carcinogenesis via β-catenin and snail CB Prasad, D Singh, LK Pandey, S Pradhan, S Singh, G Narayan The International Journal of Biochemistry & Cell Biology 142, 106122, 2022 | 20 | 2022 |
| PARP1 rs1136410 (A/G) polymorphism is associated with early age of onset of gallbladder cancer K Anjali, D Singh, P Kumar, T Kumar, G Narayan, S Singh European Journal of Cancer Prevention 31 (4), 311-317, 2022 | 8 | 2022 |
| Frequent promoter hypermethylation and down regulation of BNIP3: an early event during gallbladder cancer progression A Bharti, AG Kar, D Singh, MA Ansari, M Tewari, G Narayan, S Singh Digestive and Liver Disease 54 (9), 1257-1263, 2022 | 7 | 2022 |
| TRAIL receptors are differentially regulated and clinically significant in gallbladder cancer D Singh, CB Prasad, D Biswas, M Tewari, AG Kar, MA Ansari, S Singh, ... Pathology 52 (3), 348-358, 2020 | 5 | 2020 |
| The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity CB Prasad, A Oo, Y Liu, Z Qiu, Y Zhong, N Li, D Singh, X Xin, YJ Cho, Z Li, ... Nature Communications 15 (1), 4667, 2024 | 3 | 2024 |
| PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer D Singh, Z Qiu, SM Jonathan, P Fa, H Thomas, CB Prasad, S Cai, ... Cancer letters 598, 217110, 2024 | 1 | 2024 |
| Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer D Singh, A Bharti, D Biswas, M Tewari, AG Kar, MA Ansari, S Singh, ... Journal of Gastrointestinal Cancer, 1-8, 2021 | 1 | 2021 |
| Abstract B024: The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity CB Prasad, A Oo, Z Qiu, N Li, D Singh, X Xin, YJ Cho, Z Li, X Zhang, ... Cancer Research 84 (1_Supplement), B024-B024, 2024 | | 2024 |
| Clinical Significance of Overexpression of Oct4 in Advanced Stage Gallbladder Carcinoma D Singh, D Biswas, M Tewari, AG Kar, MA Ansari, S Singh, G Narayan Journal of Gastrointestinal Cancer 54 (4), 1231-1239, 2023 | | 2023 |
| DNA Damage Response: A Therapeutic Landscape For Breast Cancer Treatment DS CB Prasad Breast Cancer: Current Trends in Molecular Research 1, 62-85, 2022 | | 2022 |
| Protective role of ERCC4 SNP rs1800067 Minor Allele in Gallbladder Carcinogenesis. K Anjali, D Singh, P Kumar, T Kumar, G Narayan, S Singh | | 2021 |
| Altered expression of NKX3. 1 has significant prognostic value in gallbladder cancer D Singh, A Bharti, D Biswas, M Tewari, MA Ansari, S Singh, G Narayan Gene Reports 17, 100518, 2019 | | 2019 |
| Molecular Pathology of Gallbladder Carcinogenesis study of critical genes at 8p21 23 and stem cell marker OCT4 D Singh Varanasi, 0 | | |
Gopeshwar NarayanProfessor, Department of Molecular & Human Genetics, Banaras Hindu University在 bhu.ac.in 的电子邮件经过验证
